Licenses and licensing conditions may vary from country to country. Please always consult your country specific SPC or package leaflet.

Privacy at Baxter

In the regular course of business, Baxter interacts and communicates directly with consumers, patients, health-care professionals, employees and others. These audiences may share their personally identifiable information with Baxter which we collect, store and process electronically and/or manually. Please see the following Global Privacy Principles that govern Baxter´s use of personally identifiable information ("Private Information"). Since Baxter has many websites developed by Baxter business units and regions that can be accessed via the www.baxter.com site, please also see the information provided in the section entitled "Baxter´s Website Policies" below.

IMPORTANT: Baxter´s Global Privacy Statement states: "In all instances, Baxter believes that it is a person´s right to have their personal information kept private. Therefore, we have an obligation to implement privacy procedures and technical security measures to keep personal information private and secure." If you should have any questions concerning Baxter´s privacy practices or wish to access or correct Private Information that Baxter has collected from you, please submit an inquiry via Baxters on-line Privacy Inquiry Form, call: 1-800-422-9837 (847-948-4770) or fax your inquiry to 847-948-3642.

Are you a Healthcare Professional?


  I am not a Healthcare Professional            I am a Healthcare Professional

Please click "Accept" to continue:
Read & scroll down to accept the Policy Statement
Select Region:
Text Size:
Glossary  |  Site Map  |  Contact Us  |  News Room
BioTherapeutics Baxter wordmark link to corporate website

Therapeutic Areas | Immunoglobulins

Licenses and licensing conditions may vary from country to country. Please always consult your country specific SPC or package leaflet.
For additional resources, please click here.

Product Primary Uses Product Description
KIOVIG

Human Normal Immunoglobulin (IVIg)
Replacement therapy for primary and secondary immunodeficiencies, children with AIDS, ITP, Guillain-Barré Syndrome, Kawasaki disease, and Allogeneic Bone Marrow Transplantation

Please see SPC
1mL contains 100 mg of IVIg solution for infusion
GAMMAGARD S/D

Human normal immunoglobulin (IVIg)
Replacement therapy for primary and secondary immunodeficiencies, children with AIDS, ITP, Guillain-Barré Syndrome, Kawasaki disease, and Allogeneic Bone Marrow Transplantation

Please see SPC
Solvent/detergent treated, sterile freeze dried preparation of highly purified IgG
SUBCUVIA

Human Normal Immunoglobulin for Subcutaneous Use
Replacement therapy for adults and children with primary, secondary immunodeficiencies and recurrent infections

Please see SPC
10% solution of polyvalent human normal immunoglobulin for subcutaneous infusion
WinRho® SDF

Human Anti-D (Rh0) Immunoglobulin
Treatment of Immune Thrombocytopenic Purpura (ITP) in Rh0 (D) positive, non-splenectomised patients

Please see SPCs
Powder and solvent for solution or injection
TETABULIN S/D

Human tetanus immunoglobulin for intramuscular use
Post-exposure prophylaxis
Therapy of clinically manifested tetanus

Please see SPC
Ready to use 16% solution for IM use
PARTOBULIN SDF

Human anti-D immunoglobulin for intramuscular use
Prevention of Rh(D) immunisation in Rh(D) negative women

Please see SPC
Ready-to-use 16% solution for 1mL use, one ml contains 1250 IU human anti-D immunoglobulin

THERAPEUTIC AREAS

FEATURED PRODUCTS

Gammagard SD

Powder and solvent for solution containing 0.5g, 2.5g, 5g, and 10g IgG per vial

Please see SPC

Subcuvia

16% solution of polyvalent human normal immunoglobulin for subcutaneous infusion

Please see SPC